Neuron Specific Enolase in Ventricular Assist Device Recipients

Completed

Conditions studied: Advanced Heart Failure, Left Ventrucular Assist Device

In brief

An observational study of neuron specific enolase, as a marker of reperfusion injury, in LVAD recipients before and following VAD implantation.

Key facts

Study ID

NCT01643551

Run by

University of Minnesota

People needed

15

Starts

2012-06-01

Expected to finish

2013-07-01

Last updated by the study team

2014-12-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Group 1 - Pre-VAD implantation patients
• 18 years and older
• lanning to undergo VAD implantation Group 2 Cardiac Surgery Comparison Group
• 18 years or older
• Planning to undergo valve or coronary bypass surgery

You may not qualify if…

• Acute cerebrovascular infarction

Where it is running

• University of Minnesota Medical Center-Fairview — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.